Arkolith/Insider Trading/TOVX

TOVX Insider Trading

Theriva Biologics, Inc. · full profile →Last filing Jan 5, 2026

Theriva Biologics, Inc. also files under SYN, AEN, PP, PPEX, PPXP, OTCBB:SFPH, SFPH; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jan 5, 2026Shallcross Steven ACEO and CFO, DirectorGrant(A)475K—$0
Jan 5, 2026Monahan John JDirectorGrant(A)75K—$0
Jan 5, 2026Kraws Jeffrey JDirectorGrant(A)75K—$0
Jan 5, 2026Wolf Jeffrey AlanDirectorGrant(A)75K—$0
Apr 29, 2025Shallcross Steven ACEO and CFO, DirectorGrant(A)190K—$0
Apr 29, 2025Wolf Jeffrey AlanDirectorGrant(A)25K—$0
Apr 29, 2025Monahan John JDirectorGrant(A)25K—$0
Apr 29, 2025Kraws Jeffrey JDirectorGrant(A)25K—$0
Dec 14, 2023Monahan John JDirectorGrant(A)110K—$0
Dec 14, 2023Wolf Jeffrey AlanDirectorGrant(A)110K—$0
Dec 14, 2023Shallcross Steven ACEO and CFO, DirectorGrant(A)700K—$0
Dec 14, 2023Kraws Jeffrey JDirectorGrant(A)110K—$0
Jun 7, 2023Shallcross Steven ACEO and CFO, DirectorBuy(P)14K$0.69$10K
Jun 6, 2023Shallcross Steven ACEO and CFO, DirectorBuy(P)26K$0.63$16K
Feb 10, 2023Shallcross Steven ACEO and CFO, DirectorBuy(P)25K$1.04$26K
Feb 2, 2023Shallcross Steven ACEO and CFO, DirectorBuy(P)25K$0.94$24K
Jan 25, 2023Shallcross Steven ACEO and CFO, DirectorBuy(P)25K$0.87$22K
Jan 20, 2023Shallcross Steven ACEO and CFO, DirectorBuy(P)25K$0.75$19K
Dec 29, 2022Shallcross Steven ACEO and CFO, DirectorBuy(P)100K$0.44$44K
Dec 15, 2022Tufaro FrancisChief Operating OfficerGrant(A)100K—$0
Dec 15, 2022Kraws Jeffrey JDirectorGrant(A)100K—$0
Dec 15, 2022Wolf Jeffrey AlanDirectorGrant(A)100K—$0
Dec 15, 2022Monahan John JDirectorGrant(A)100K—$0
Dec 15, 2022Shallcross Steven ACEO and CFO, DirectorGrant(A)475K—$0
Dec 23, 2021Kraws Jeffrey JDirectorGrant(A)200K—$0
Dec 23, 2021Wolf Jeffrey AlanDirectorGrant(A)200K—$0
Dec 23, 2021Monahan John JDirectorGrant(A)200K—$0
Dec 23, 2021Shallcross Steven ACEO and CFO, DirectorGrant(A)650K—$0
May 10, 2021Shallcross Steven ACEO and CFO, DirectorBuy(P)50K$0.49$25K
Dec 30, 2020Monahan John JDirectorGrant(A)150K—$0
Dec 30, 2020Kraws Jeffrey JDirectorGrant(A)150K—$0
Dec 30, 2020Wolf Jeffrey AlanDirectorGrant(A)150K—$0
Dec 30, 2020Shallcross Steven ACEO and CFO, DirectorGrant(A)450K—$0
Dec 4, 2019Tarriff ScottDirectorGrant(A)250K—$0
Dec 4, 2019Kraws Jeffrey JDirectorGrant(A)250K—$0
Dec 4, 2019Wolf Jeffrey AlanDirectorGrant(A)250K—$0
Dec 4, 2019Shallcross Steven ACEO and CFO, DirectorGrant(A)450K—$0
Aug 23, 2019Shallcross Steven ACEO and CFO, DirectorBuy(P)50K$0.42$21K
Apr 3, 2019Intrexon Corp10% OwnerSell(S)26K$0.65$17K
Apr 3, 2019Intrexon Corp10% OwnerSell(S)69K$0.65$45K
Apr 2, 2019Intrexon Corp10% OwnerSell(S)4K$0.66$2K
Apr 2, 2019Intrexon Corp10% OwnerSell(S)10K$0.66$7K
Apr 1, 2019Intrexon Corp10% OwnerSell(S)30K$0.67$20K
Apr 1, 2019Intrexon Corp10% OwnerSell(S)11K$0.67$8K
Dec 6, 2018Kraws Jeffrey JDirectorGrant(A)80K—$0
Dec 6, 2018Shallcross Steven ACEO and CFO, DirectorGrant(A)200K—$0
Dec 6, 2018Wolf Jeffrey AlanDirectorGrant(A)80K—$0
Dec 6, 2018Tarriff ScottDirectorGrant(A)80K—$0
Dec 20, 2017Kraws Jeffrey JDirectorGrant(A)200K—$0
Dec 20, 2017Sliman Joseph A.Chief Medical OfficerGrant(A)410K—$0
Dec 20, 2017Wolf Jeffrey AlanDirectorGrant(A)200K—$0
Dec 20, 2017Tarriff ScottDirectorGrant(A)200K—$0
Dec 20, 2017Shallcross Steven AInterim CEO and CFOGrant(A)550K—$0
Mar 14, 2017Kraws Jeffrey JDirectorOption exercise(M)229K$0.09$21K
Mar 14, 2017Kraws Jeffrey JDirectorOption exercise(M)229K—$0
Jan 17, 2017Sliman Joseph A.Chief Medical OfficerGrant(A)189K—$0
Nov 30, 2016Wolf Jeffrey AlanDirectorGrant(A)169K—$0
Nov 30, 2016Kraws Jeffrey JDirectorGrant(A)169K—$0
Nov 30, 2016Shallcross Steven AChief Financial OfficerGrant(A)500K—$0
Nov 30, 2016Riley Jeffrey ScottChief Executive Officer, DirectorGrant(A)1.1M—$0
Nov 30, 2016Tarriff ScottDirectorGrant(A)169K—$0
Nov 18, 2016Tarriff ScottDirectorGrant(A)300K——
Nov 18, 2016Tarriff ScottDirectorGrant(A)300K——
Nov 18, 2016Tarriff ScottDirectorGrant(A)300K——
Dec 4, 2015Riley Jeffrey ScottChief Executive Officer, DirectorGrant(A)500K—$0
Dec 4, 2015Kraws Jeffrey JDirectorGrant(A)125K—$0
Dec 4, 2015Tarriff ScottDirectorGrant(A)125K—$0
Dec 4, 2015Wolf Jeffrey AlanDirectorGrant(A)125K—$0
Dec 4, 2015Shallcross Steven AChief Financial OfficerGrant(A)100K—$0
Sep 2, 2015Kirk Randal J10% OwnerBuy(P)938K$3.20$3.0M
Jun 1, 2015Shallcross Steven AChief Financial OfficerGrant(A)900K—$0
Apr 1, 2015Wolf Jeffrey AlanDirectorOption exercise(M)11K$0.09$976
Apr 1, 2015Wolf Jeffrey AlanDirectorOption exercise(M)11K—$0
Jan 8, 2015Ballantyne Charles EvanChief Financial OfficerGrant(A)200K—$0
Jan 8, 2015Riley Jeffrey ScottCEO and President, DirectorGrant(A)350K—$0
May 22, 2014Ballantyne Charles EvanChief Financial OfficerBuy(P)10K$1.35$14K
Apr 30, 2014Kanzer Steve H10% OwnerSell(S)5.0M$1.43$7.2M
Apr 29, 2014Kanzer Steve H10% OwnerSell(S)88K$2.98$262K
Apr 28, 2014Kanzer Steve H10% OwnerSell(S)175K$2.86$501K
Apr 17, 2014Tarriff ScottDirectorGrant(A)105K—$0
Apr 17, 2014Ballantyne Charles EvanChief Financial OfficerGrant(A)150K—$0
Apr 17, 2014Kraws Jeffrey JDirectorGrant(A)105K—$0
Apr 17, 2014Riley Jeffrey ScottCEO and President, DirectorGrant(A)500K—$0
Apr 17, 2014Wolf Jeffrey AlanDirectorGrant(A)105K—$0
Dec 17, 2013Intrexon Corp10% OwnerBuy(P)500K$1.00$500K
Dec 17, 2013Intrexon Corp10% OwnerBuy(P)2.0M$1.00$2.0M
Oct 22, 2013Wolf Jeffrey AlanDirectorGrant(A)25K—$0
Oct 22, 2013Tarriff ScottDirectorGrant(A)25K—$0
Oct 22, 2013Kraws Jeffrey JDirectorGrant(A)25K—$0
Mar 5, 2013Tarriff ScottDirectorGrant(A)25K$1.74$44K
Mar 5, 2013Wolf Jeffrey AlanDirectorGrant(A)25K$1.74$44K
Jan 7, 2013Riley Jeffrey ScottCEO and President, DirectorBuy(P)5$1.71$9
Jan 7, 2013Riley Jeffrey ScottCEO and President, DirectorBuy(P)3K$0.17$492
Jan 3, 2013Riley Jeffrey ScottCEO and President, DirectorBuy(P)2K$1.71$3K
Jan 3, 2013Riley Jeffrey ScottCEO and President, DirectorBuy(P)3K$1.75$5K
Jan 2, 2013Riley Jeffrey ScottCEO and President, DirectorBuy(P)3K$1.78$5K
Oct 29, 2012Kirk Randal J10% OwnerBuy(P)3.1M$1.60$5.0M
May 10, 2012Kraws Jeffrey JDirectorGrant(A)100K—$0
Feb 3, 2012Riley Jeffrey ScottCEO and President, DirectorGrant(A)750K—$0
Nov 17, 2011Riley Jeffrey ScottDirectorGrant(A)100K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Theriva Biologics, Inc., SEC CIK 0000894158. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under TOVX and shows every filing by that issuer (also filed as SYN, AEN, PP, PPEX, PPXP, OTCBB:SFPH, SFPH).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for TOVX